Leap Therapeutics Dividend
Dividend criteria checks 0/6
Leap Therapeutics does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
Industry average yield | 2.8% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | -US$1.39 |
Dividend yield forecast in 3Y | n/a |
Recent dividend updates
No updates
Recent updates
Is Leap Therapeutics (NASDAQ:LPTX) In A Good Position To Deliver On Growth Plans?
Mar 13Will Leap Therapeutics (NASDAQ:LPTX) Spend Its Cash Wisely?
Nov 22Leap Therapeutics GAAP EPS of -$0.15 misses by $0.05
Aug 12Leap Therapeutics begins trials of DKN-01 in gastric/colorectal cancers
Jul 12Leap Therapeutics: 2 Catalysts With Cancer Drug DKN-01 In The 2nd Half Of 2022
Jun 27Here's Why We're Watching Leap Therapeutics' (NASDAQ:LPTX) Cash Burn Situation
May 01Leap Therapeutics: Waiting For One More Leap
Feb 18We're Hopeful That Leap Therapeutics (NASDAQ:LPTX) Will Use Its Cash Wisely
Jan 04Leap Therapeutics: What Prompted Prioritizing This Precision Oncology Company?
Nov 29Leap Therapeutics: All On The Line
Oct 13Is Leap Therapeutics (NASDAQ:LPTX) In A Good Position To Invest In Growth?
Sep 15Is Leap Therapeutics (NASDAQ:LPTX) In A Good Position To Invest In Growth?
Jun 01Companies Like Leap Therapeutics (NASDAQ:LPTX) Are In A Position To Invest In Growth
Mar 03Could The Leap Therapeutics, Inc. (NASDAQ:LPTX) Ownership Structure Tell Us Something Useful?
Jan 27Announcing: Leap Therapeutics (NASDAQ:LPTX) Stock Increased An Energizing 127% In The Last Year
Dec 23Need To Know: Analysts Are Much More Bullish On Leap Therapeutics, Inc. (NASDAQ:LPTX)
Nov 18Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if LPTX's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if LPTX's dividend payments have been increasing.
Dividend Yield vs Market
Leap Therapeutics Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (LPTX) | n/a |
Market Bottom 25% (US) | 1.5% |
Market Top 25% (US) | 4.6% |
Industry Average (Biotechs) | 2.8% |
Analyst forecast in 3 Years (LPTX) | n/a |
Notable Dividend: Unable to evaluate LPTX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate LPTX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate LPTX's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as LPTX has not reported any payouts.